Adar1 Capital Management, LLC Lexaria Bioscience Corp. Transaction History

Adar1 Capital Management, LLC

  • $615 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$1.99 - $4.0 $51,105 - $102,724
-25,681 Reduced 96.45%
945 $2.63 Million
Q1 2024

May 15, 2024
BUY
$1.29 - $6.25 $32,250 - $156,250
25,000 Added 1537.52%
26,626 $96.7 Million
Q4 2023

Feb 14, 2024
BUY
$0.92 - $1.69 $1,495 - $2,747
1,626 New
1,626 $2.03 Million

Others Institutions Holding LEXX

# of Institutions
27
Shares Held
1.06M
Call Options Held
0
Put Options Held
0
View Full List

About Lexaria Bioscience Corp.

LEXX Quotes by TradingView
  • Ticker LEXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,951,000
  • Market Cap $13.7M
  • Description
  • Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...
More about LEXX
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email